Junghans RP - Search Results

1

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

Chamow SM, Zhang DZ, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP. Chamow SM, et al. Among authors: junghans rp. J Immunol. 1994 Nov 1;153(9):4268-80. J Immunol. 1994. PMID: 7930627

2

A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells.

Chamow SM, Zhang D, Tan XY, Mhatre SM, Marsters SA, Peers DH, Byrn RA, Ashkenazi A, Junghans RP. Chamow SM, et al. Among authors: junghans rp. J Hematother. 1995 Oct;4(5):439-46. doi: 10.1089/scd.1.1995.4.439. J Hematother. 1995. PMID: 8581382

3

An advanced solid support for immunoassays and other affinity applications.

Schmidt DE Jr, Brooks TL, Mhatre S, Junghans RP, Khazaeli MB. Schmidt DE Jr, et al. Among authors: junghans rp. Biotechniques. 1993 Jun;14(6):1020-5. Biotechniques. 1993. PMID: 8333946

4

A humanized antibody that binds to the interleukin 2 receptor.

Queen C, Schneider WP, Selick HE, Payne PW, Landolfi NF, Duncan JF, Avdalovic NM, Levitt M, Junghans RP, Waldmann TA. Queen C, et al. Among authors: junghans rp. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10029-33. doi: 10.1073/pnas.86.24.10029. Proc Natl Acad Sci U S A. 1989. PMID: 2513570 Free PMC article.

5

Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Katz SC, Ryan K, Ahmed N, Plitas G, Chaudhry UI, Kingham TP, Naheed S, Nguyen C, Somasundar P, Espat NJ, Junghans RP, Dematteo RP. Katz SC, et al. Among authors: junghans rp. J Immunol. 2011 Aug 1;187(3):1150-6. doi: 10.4049/jimmunol.1004077. Epub 2011 Jun 22. J Immunol. 2011. PMID: 21697460 Free PMC article.

6

Direct immunoprecipitation of antigen with phage displaying immunoglobulin fragment.

Telleman P, Kingsbury GA, Junghans RP. Telleman P, et al. Among authors: junghans rp. Biotechniques. 2000 Dec;29(6):1240-2, 1244, 1246 passim. doi: 10.2144/00296st04. Biotechniques. 2000. PMID: 11126127 Free article.

7

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.

Junghans RP, Waldmann TA, Landolfi NF, Avdalovic NM, Schneider WP, Queen C. Junghans RP, et al. Cancer Res. 1990 Mar 1;50(5):1495-502. Cancer Res. 1990. PMID: 2406013

8

A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin.

Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan I. Chaudhary VK, et al. Among authors: junghans rp. Nature. 1989 Jun 1;339(6223):394-7. doi: 10.1038/339394a0. Nature. 1989. PMID: 2498664

9

Impact of antigenemia on the bioactivity of infused anti-Tac antibody: implications for dose selection in antibody immunotherapies.

Junghans RP, Carrasquillo JA, Waldmann TA. Junghans RP, et al. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1752-7. doi: 10.1073/pnas.95.4.1752. Proc Natl Acad Sci U S A. 1998. PMID: 9465089 Free PMC article.

10

Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.

Brown PS Jr, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR, et al. Brown PS Jr, et al. Among authors: junghans rp. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2663-7. doi: 10.1073/pnas.88.7.2663. Proc Natl Acad Sci U S A. 1991. PMID: 2011577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters